Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1597 to 1608 of 1616 entries
Sorted by: Best Match Show Resources per page
The effect of chemicals on the activity of deglycosylated Aureobasidiumβ-fructofuranosidases.

Letters in applied microbiology

Hayashi S, Tubouchi M, Takasaki Y, Imada K.
PMID: 34892916
Lett Appl Microbiol. 1994 Feb;18(2):105-106. doi: 10.1111/j.1472-765X.1994.tb00817.x.

The effects of chemicals such as metal ions and typical organic enzyme inhibitors on the activity of deglycosylated β-fructofuranosidases (P-1 and P-2) from Aureobasidium were observed and compared with those of native enzymes. P-1 and P-2 enzymes became sensitive...

Cite
Hayashi S, Tubouchi M, Takasaki Y, et al. The effect of chemicals on the activity of deglycosylated Aureobasidiumβ-fructofuranosidases. Lett Appl Microbiol. 1994;18(2):105-106doi: 10.1111/j.1472-765X.1994.tb00817.x.
Hayashi, S., Tubouchi, M., Takasaki, Y., & Imada, K. (1994). The effect of chemicals on the activity of deglycosylated Aureobasidiumβ-fructofuranosidases. Letters in applied microbiology, 18(2), 105-106. https://doi.org/10.1111/j.1472-765X.1994.tb00817.x
Hayashi, S, et al. "The effect of chemicals on the activity of deglycosylated Aureobasidiumβ-fructofuranosidases." Letters in applied microbiology vol. 18,2 (1994): 105-106. doi: https://doi.org/10.1111/j.1472-765X.1994.tb00817.x
Hayashi S, Tubouchi M, Takasaki Y, Imada K. The effect of chemicals on the activity of deglycosylated Aureobasidiumβ-fructofuranosidases. Lett Appl Microbiol. 1994 Feb;18(2):105-106. doi: 10.1111/j.1472-765X.1994.tb00817.x. PMID: 34892916.
Copy Download .nbib Format: NLM
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: ​a systematic review and meta-analysis.

Singapore medical journal

Cai XJ, Tay JCK, Kui SL, Tin AS, Tan VH.
PMID: 33256355
Singapore Med J. 2020 Nov 30; doi: 10.11622/smedj.2020159. Epub 2020 Nov 30.

INTRODUCTION: There are concerns that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) may worsen outcomes in patients with coronavirus disease 2019 (COVID-19). This systemic review and meta-analysis aimed to study in-hospital mortality in COVID-19 patients who were...

Cite
Cai XJ, Tay JCK, Kui SL, et al. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: ​a systematic review and meta-analysis. Singapore Med J. 2020;doi: 10.11622/smedj.2020159.
Cai, X. J., Tay, J. C. K., Kui, S. L., Tin, A. S., & Tan, V. H. (2020). Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: ​a systematic review and meta-analysis. Singapore medical journal, . https://doi.org/10.11622/smedj.2020159
Cai, Xinzhe James, et al. "Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: ​a systematic review and meta-analysis." Singapore medical journal vol. (2020). doi: https://doi.org/10.11622/smedj.2020159
Cai XJ, Tay JCK, Kui SL, Tin AS, Tan VH. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: ​a systematic review and meta-analysis. Singapore Med J. 2020 Nov 30; doi: 10.11622/smedj.2020159. Epub 2020 Nov 30. PMID: 33256355.
Copy Download .nbib Format: NLM
The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.

Molecular biology reports

Moreira FRC, de Oliveira TA, Ramos NE, Abreu MAD, Simões E Silva AC.
PMID: 34417705
Mol Biol Rep. 2021 Sep;48(9):6619-6629. doi: 10.1007/s11033-021-06672-8. Epub 2021 Aug 20.

BACKGROUND: In rheumatoid arthritis (RA) and osteoarthritis (OA), chronic inflammatory processes lead to progresive joint destruction. The renin-angiotensin system (RAS) is involved in the pathogenesis of RA and OA. The aim of this mini-review article is to summarize evidence...

Cite
Moreira FRC, de Oliveira TA, Ramos NE, et al. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis. Mol Biol Rep. 2021;48(9):6619-6629doi: 10.1007/s11033-021-06672-8.
Moreira, F. R. C., de Oliveira, T. A., Ramos, N. E., Abreu, M. A. D., & Simões E Silva, A. C. (2021). The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis. Molecular biology reports, 48(9), 6619-6629. https://doi.org/10.1007/s11033-021-06672-8
Moreira, Fernanda Rocha Chaves, et al. "The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis." Molecular biology reports vol. 48,9 (2021): 6619-6629. doi: https://doi.org/10.1007/s11033-021-06672-8
Moreira FRC, de Oliveira TA, Ramos NE, Abreu MAD, Simões E Silva AC. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis. Mol Biol Rep. 2021 Sep;48(9):6619-6629. doi: 10.1007/s11033-021-06672-8. Epub 2021 Aug 20. PMID: 34417705.
Copy Download .nbib Format: NLM
Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer.

Frontiers in oncology

Ji Z, Shen Y, Feng X, Kong Y, Shao Y, Meng J, Zhang X, Yang G.
PMID: 33194756
Front Oncol. 2020 Oct 19;10:593017. doi: 10.3389/fonc.2020.593017. eCollection 2020.

Ovarian cancer is one of the most malignant gynecological cancers around the world. In spite of multiple treatment options, the five-year survival rate is still very low. Several metabolism alterations are described as a hallmark in cancers, but alterations...

Cite
Ji Z, Shen Y, Feng X, et al. Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer. Front Oncol. 2020;10:593017doi: 10.3389/fonc.2020.593017.
Ji, Z., Shen, Y., Feng, X., Kong, Y., Shao, Y., Meng, J., Zhang, X., & Yang, G. (2020). Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer. Frontiers in oncology, 10593017. https://doi.org/10.3389/fonc.2020.593017
Ji, Zhaodong, et al. "Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer." Frontiers in oncology vol. 10 (2020): 593017. doi: https://doi.org/10.3389/fonc.2020.593017
Ji Z, Shen Y, Feng X, Kong Y, Shao Y, Meng J, Zhang X, Yang G. Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer. Front Oncol. 2020 Oct 19;10:593017. doi: 10.3389/fonc.2020.593017. eCollection 2020. PMID: 33194756; PMCID: PMC7604390.
Copy Download .nbib Format: NLM
Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer.

Southern medical journal

Helgeson SA, Waddle MR, Burnside RC, Debella YT, Lee AS, Burger CD, Li Z, Johnson PW, Patel NM.
PMID: 34480196
South Med J. 2021 Sep;114(9):607-613. doi: 10.14423/SMJ.0000000000001293.

OBJECTIVES: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are the most commonly prescribed antihypertensives, with prior studies identifying a possible association between long-term use and increased rates of lung cancer. This study evaluated this potential association in...

Cite
Helgeson SA, Waddle MR, Burnside RC, et al. Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer. South Med J. 2021;114(9):607-613doi: 10.14423/SMJ.0000000000001293.
Helgeson, S. A., Waddle, M. R., Burnside, R. C., Debella, Y. T., Lee, A. S., Burger, C. D., Li, Z., Johnson, P. W., & Patel, N. M. (2021). Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer. Southern medical journal, 114(9), 607-613. https://doi.org/10.14423/SMJ.0000000000001293
Helgeson, Scott A, et al. "Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer." Southern medical journal vol. 114,9 (2021): 607-613. doi: https://doi.org/10.14423/SMJ.0000000000001293
Helgeson SA, Waddle MR, Burnside RC, Debella YT, Lee AS, Burger CD, Li Z, Johnson PW, Patel NM. Association between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Lung Cancer. South Med J. 2021 Sep;114(9):607-613. doi: 10.14423/SMJ.0000000000001293. PMID: 34480196.
Copy Download .nbib Format: NLM
Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases.

The Journal of pharmacology and experimental therapeutics

Goldstein DS, Castillo G, Sullivan P, Sharabi Y.
PMID: 34503991
J Pharmacol Exp Ther. 2021 Nov;379(3):253-259. doi: 10.1124/jpet.121.000826. Epub 2021 Sep 09.

The endogenous catecholamines dopamine (DA), norepinephrine (NE), and epinephrine (EPI) play key roles in neurobehavioral, cardiovascular, and metabolic processes; various clinical disorders; and effects of numerous drugs. Steps in intracellular catecholamine synthesis and metabolism were delineated long ago, but...

Cite
Goldstein DS, Castillo G, Sullivan P, et al. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases. J Pharmacol Exp Ther. 2021;379(3):253-259doi: 10.1124/jpet.121.000826.
Goldstein, D. S., Castillo, G., Sullivan, P., & Sharabi, Y. (2021). Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases. The Journal of pharmacology and experimental therapeutics, 379(3), 253-259. https://doi.org/10.1124/jpet.121.000826
Goldstein, David S, et al. "Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases." The Journal of pharmacology and experimental therapeutics vol. 379,3 (2021): 253-259. doi: https://doi.org/10.1124/jpet.121.000826
Goldstein DS, Castillo G, Sullivan P, Sharabi Y. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases. J Pharmacol Exp Ther. 2021 Nov;379(3):253-259. doi: 10.1124/jpet.121.000826. Epub 2021 Sep 09. PMID: 34503991.
Copy Download .nbib Format: NLM
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis.

American journal of therapeutics

Kashour T, Bin Abdulhak AA, Tlayjeh H, Hassett LC, Noman A, Mohsen A, Al-Mallah MH, Tleyjeh IM.
PMID: 33201001
Am J Ther. 2020 Nov 10; doi: 10.1097/MJT.0000000000001281. Epub 2020 Nov 10.

BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are known to increase the expression of angiotensin converting enzyme 2 receptor, which has been shown to be the receptor for the acute severe respiratory syndrome coronavirus 2...

Cite
Kashour T, Bin Abdulhak AA, Tlayjeh H, et al. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. Am J Ther. 2020;doi: 10.1097/MJT.0000000000001281.
Kashour, T., Bin Abdulhak, A. A., Tlayjeh, H., Hassett, L. C., Noman, A., Mohsen, A., Al-Mallah, M. H., & Tleyjeh, I. M. (2020). Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. American journal of therapeutics, . https://doi.org/10.1097/MJT.0000000000001281
Kashour, Tarek, et al. "Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis." American journal of therapeutics vol. (2020). doi: https://doi.org/10.1097/MJT.0000000000001281
Kashour T, Bin Abdulhak AA, Tlayjeh H, Hassett LC, Noman A, Mohsen A, Al-Mallah MH, Tleyjeh IM. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. Am J Ther. 2020 Nov 10; doi: 10.1097/MJT.0000000000001281. Epub 2020 Nov 10. PMID: 33201001.
Copy Download .nbib Format: NLM
Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.

Annals of internal medicine

Mackey K, Kansagara D, Vela K.
PMID: 33900794
Ann Intern Med. 2021 Jun;174(6):W54-W55. doi: 10.7326/L21-0223. Epub 2021 Apr 27.

No abstract available.

Cite
Mackey K, Kansagara D, Vela K. Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021;174(6):W54-W55doi: 10.7326/L21-0223.
Mackey, K., Kansagara, D., & Vela, K. (2021). Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Annals of internal medicine, 174(6), W54-W55. https://doi.org/10.7326/L21-0223
Mackey, Katherine, et al. "Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults." Annals of internal medicine vol. 174,6 (2021): W54-W55. doi: https://doi.org/10.7326/L21-0223
Mackey K, Kansagara D, Vela K. Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 Jun;174(6):W54-W55. doi: 10.7326/L21-0223. Epub 2021 Apr 27. PMID: 33900794; PMCID: PMC8082523.
Copy Download .nbib Format: NLM
COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

St John MH, Barry AR.
PMID: 33193917
Can Pharm J (Ott). 2020 Jun 14;153(4):193-197. doi: 10.1177/1715163520929373. eCollection 2020.

No abstract available.

Cite
St John MH, Barry AR. COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Can Pharm J (Ott). 2020;153(4):193-197doi: 10.1177/1715163520929373.
St John, M. H., & Barry, A. R. (2020). COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC, 153(4), 193-197. https://doi.org/10.1177/1715163520929373
St John, Megan H, and Barry, Arden R. "COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers." Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC vol. 153,4 (2020): 193-197. doi: https://doi.org/10.1177/1715163520929373
St John MH, Barry AR. COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Can Pharm J (Ott). 2020 Jun 14;153(4):193-197. doi: 10.1177/1715163520929373. eCollection 2020. PMID: 33193917; PMCID: PMC7605072.
Copy Download .nbib Format: NLM
The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (.

Frontiers in immunology

Chowdhury A, Lewin MR, Zdenek CN, Carter R, Fry BG.
PMID: 34691069
Front Immunol. 2021 Oct 07;12:752442. doi: 10.3389/fimmu.2021.752442. eCollection 2021.

African spitting cobras are unique among cobras for their potent anticoagulant venom activity arising from strong inhibition of Factor Xa. This anticoagulant effect is exerted by venom phospholipase A

Cite
Chowdhury A, Lewin MR, Zdenek CN, et al. The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (. Front Immunol. 2021;12:752442doi: 10.3389/fimmu.2021.752442.
Chowdhury, A., Lewin, M. R., Zdenek, C. N., Carter, R., & Fry, B. G. (2021). The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (. Frontiers in immunology, 12752442. https://doi.org/10.3389/fimmu.2021.752442
Chowdhury, Abhinandan, et al. "The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (." Frontiers in immunology vol. 12 (2021): 752442. doi: https://doi.org/10.3389/fimmu.2021.752442
Chowdhury A, Lewin MR, Zdenek CN, Carter R, Fry BG. The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (. Front Immunol. 2021 Oct 07;12:752442. doi: 10.3389/fimmu.2021.752442. eCollection 2021. PMID: 34691069; PMCID: PMC8529177.
Copy Download .nbib Format: NLM
Consensus on basic conduct during the hospital admission of patients with acute heart failure.

Revista clinica espanola

Fernández Rodríguez JM, Casado J, Formiga F, González-Franco Á, Arévalo JC, Beltrán M, Cerqueiro González JM, Llàcer P, Manzano L, Morales-Rull JL, Pérez Silvestre J, Conde-Martel A.
PMID: 33998516
Rev Clin Esp (Barc). 2021 May;221(5):283-296. doi: 10.1016/j.rceng.2020.01.010. Epub 2021 Mar 27.

Acute heart failure (AHF) is a highly prevalent clinical entity in individuals older than 45 years in Spain. AHF is associated with significant morbidity and mortality and is the leading cause of hospitalisation for individuals older than 65 years...

Cite
Fernández Rodríguez JM, Casado J, Formiga F, et al. Consensus on basic conduct during the hospital admission of patients with acute heart failure. Rev Clin Esp (Barc). 2021;221(5):283-296doi: 10.1016/j.rceng.2020.01.010.
Fernández Rodríguez, J. M., Casado, J., Formiga, F., González-Franco, �. �., Arévalo, J. C., Beltrán, M., Cerqueiro González, J. M., Llàcer, P., Manzano, L., Morales-Rull, J. L., Pérez Silvestre, J., & Conde-Martel, A. (2021). Consensus on basic conduct during the hospital admission of patients with acute heart failure. Revista clinica espanola, 221(5), 283-296. https://doi.org/10.1016/j.rceng.2020.01.010
Fernández Rodríguez, J M, et al. "Consensus on basic conduct during the hospital admission of patients with acute heart failure." Revista clinica espanola vol. 221,5 (2021): 283-296. doi: https://doi.org/10.1016/j.rceng.2020.01.010
Fernández Rodríguez JM, Casado J, Formiga F, González-Franco Á, Arévalo JC, Beltrán M, Cerqueiro González JM, Llàcer P, Manzano L, Morales-Rull JL, Pérez Silvestre J, Conde-Martel A. Consensus on basic conduct during the hospital admission of patients with acute heart failure. Rev Clin Esp (Barc). 2021 May;221(5):283-296. doi: 10.1016/j.rceng.2020.01.010. Epub 2021 Mar 27. PMID: 33998516.
Copy Download .nbib Format: NLM
Phytochemical Composition, Antioxidant, and Enzyme Inhibition Activities of Methanolic Extracts of Two Endemic .

Plants (Basel, Switzerland)

Saravanakumar K, Sarikurkcu C, Sahinler SS, Sarikurkcu RB, Wang MH.
PMID: 34371578
Plants (Basel). 2021 Jul 05;10(7). doi: 10.3390/plants10071373.

No abstract available.

Cite
Saravanakumar K, Sarikurkcu C, Sahinler SS, et al. Phytochemical Composition, Antioxidant, and Enzyme Inhibition Activities of Methanolic Extracts of Two Endemic . Plants (Basel). 2021;10(7)doi: 10.3390/plants10071373.
Saravanakumar, K., Sarikurkcu, C., Sahinler, S. S., Sarikurkcu, R. B., & Wang, M. H. (2021). Phytochemical Composition, Antioxidant, and Enzyme Inhibition Activities of Methanolic Extracts of Two Endemic . Plants (Basel, Switzerland), 10(7), . https://doi.org/10.3390/plants10071373
Saravanakumar, Kandasamy, et al. "Phytochemical Composition, Antioxidant, and Enzyme Inhibition Activities of Methanolic Extracts of Two Endemic ." Plants (Basel, Switzerland) vol. 10,7 (2021). doi: https://doi.org/10.3390/plants10071373
Saravanakumar K, Sarikurkcu C, Sahinler SS, Sarikurkcu RB, Wang MH. Phytochemical Composition, Antioxidant, and Enzyme Inhibition Activities of Methanolic Extracts of Two Endemic . Plants (Basel). 2021 Jul 05;10(7). doi: 10.3390/plants10071373. PMID: 34371578; PMCID: PMC8309465.
Copy Download .nbib Format: NLM
Showing 1597 to 1608 of 1616 entries